Government lawyers have cited internal business documents to question whether the deal would deplete competition in the ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

C&S also said it is committed to becoming a major supermarket operator. The company's owner, Rick Cohen, is funding $500 ...

The Senate will advance a bipartisan stopgap government funding bill on Thursday after efforts to pass a similar measure in ...

U.S. Rep. Rosa DeLauro, D-3 and Federal Trade Commission Chair Lina Khan met in New Haven to hear about the challenges facing ...

The Federal Trade Commission (FTC) is in the news again this week as its lawsuit seeking to block the Albertsons-Kroger ...

September 21, 2024 - On Friday, the Biden-⁠Harris Administration highlighted new actions to support women’s economic security ...

At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...

Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a ...

Benefits Pro: Employers Need To Stop Maximizing PBM Drug Plan Rebates, Says Mark Cuban Cuban, the founder of the Mark Cuban Cost Plus Drug mail-order pharmacy, said the main rebate funding ...

Nura Bio has secured additional $68m in a Series A financing round to advance the development of its neuroprotective ...

Lightyear, yes, Lightyear (remember them?), is reemerging from the ashes of a failed solar electric vehicle venture and has ...